PD-L1 testing in advanced stage lung cancer using cytology samples: Suitability and reporting issues. Comparison between two tertiary referral centers

    DOI Logo 10.17352/acp.000022

    Published On: January 25, 2021 | Pages: 001 - 006

    Author(s): Elshiekh Mohamed, Spinelli Manuela, Iles Sandra, Hopcroft Danielle, Trivedi Pritesh, Gupta Nandita, Bhagwat Priya and Viola Patrizia*
    Background: Lung cancer is the most common cause of cancer-related death worldwide and unfortunately up to 80% of patients amongst newly diagnosed are inoperable therefore the cytological sample is often the only material available for diagnosis and assessment of molecular characteristics driving the treatment. Recently immunotherapy has shown promising results in tum ... CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat
    Abstract View Full Article View


    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on ACP